New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Diverging effects of the COVID-19 pandemic on type 2 diabetes care processes

Diverging effects of the COVID-19 pandemic on type 2 diabetes care processes

by University of Eastern FinlandTransition of patients between contact types by usual in-person service use frequency groups Groups based on in-person contact during 16 Mar 2017 to 15 Mar 2020: A
Diabetes & Endocrinology March 14,2024
Diverging effects of the COVID-19 pandemic on type 2 diabetes care processes

Diverging effects of the COVID-19 pandemic on type 2 diabetes care processes

by University of Eastern FinlandTransition of patients between contact types by usual in-person service use frequency groups Groups based on in-person contact during 16 Mar 2017 to 15 Mar 2020: A
Diabetes & Endocrinology March 14,2024
ABT-494 effective for patients with rheumatoid arthritis

ABT-494 effective for patients with rheumatoid arthritis

(HealthDay)—A novel selective JAK-1 inhibitor, ABT-494, is effective for rheumatoid arthritis (RA) patients with inadequate response to methotrexate (MTX) or to at least one anti-tumor necrosis factor
Arthritis and Rheumatism March 14,2024
ABT-494 effective for patients with rheumatoid arthritis

ABT-494 effective for patients with rheumatoid arthritis

(HealthDay)—A novel selective JAK-1 inhibitor, ABT-494, is effective for rheumatoid arthritis (RA) patients with inadequate response to methotrexate (MTX) or to at least one anti-tumor necrosis factor
Arthritis and Rheumatism March 14,2024
For diabetes and liver cancer, study suggests new screening guidelines

For diabetes and liver cancer, study suggests new screening guidelines

by Krista Conger,Stanford University Medical CenterCollagen fibers in a three-dimensional hydrogel (left panel). When advanced glycation end products—a byproduct of poorly controlled diabetes—ar
Diabetes & Endocrinology March 14,2024
For diabetes and liver cancer, study suggests new screening guidelines

For diabetes and liver cancer, study suggests new screening guidelines

by Krista Conger,Stanford University Medical CenterCollagen fibers in a three-dimensional hydrogel (left panel). When advanced glycation end products—a byproduct of poorly controlled diabetes—ar
Diabetes & Endocrinology March 14,2024
Gut microbes may determine patients' response to a drug that delays onset of type 1 diabetes

Gut microbes may determine patients' response to a drug that delays onset of type 1 diabetes

by Delthia Ricks , Medical XpressTeplizumab delays type 1 diabetes (T1D) in at-risk individuals in TN10 trial, but participants respond differently to the treatment. Systemic, non-pathogenic antibody
Diabetes & Endocrinology March 14,2024
Gut microbes may determine patients' response to a drug that delays onset of type 1 diabetes

Gut microbes may determine patients' response to a drug that delays onset of type 1 diabetes

by Delthia Ricks , Medical XpressTeplizumab delays type 1 diabetes (T1D) in at-risk individuals in TN10 trial, but participants respond differently to the treatment. Systemic, non-pathogenic antibody
Diabetes & Endocrinology March 14,2024
3D printing a lightweight knee brace for the elderly

3D printing a lightweight knee brace for the elderly

by Nanyang Technological UniversityCentre for Orthopaedics chairman and CEO Dr Jeffery Chew helping Teo Lee Le, his patient who had two knee replacements, to wear the X-Brace. Credit: Nanyang Tec
Arthritis and Rheumatism March 14,2024
3D printing a lightweight knee brace for the elderly

3D printing a lightweight knee brace for the elderly

by Nanyang Technological UniversityCentre for Orthopaedics chairman and CEO Dr Jeffery Chew helping Teo Lee Le, his patient who had two knee replacements, to wear the X-Brace. Credit: Nanyang Tec
Arthritis and Rheumatism March 14,2024
Under-the-skin implant could treat type I diabetes

Under-the-skin implant could treat type I diabetes

by David Nutt,Cornell UniversityDesign of the SHEATH system.a, Schematic illustrating the creation of the vascularized subcutaneous site achieved by implantation of a catheter 4–6 weeks be
Diabetes & Endocrinology March 14,2024
Under-the-skin implant could treat type I diabetes

Under-the-skin implant could treat type I diabetes

by David Nutt,Cornell UniversityDesign of the SHEATH system.a, Schematic illustrating the creation of the vascularized subcutaneous site achieved by implantation of a catheter 4–6 weeks be
Diabetes & Endocrinology March 14,2024
Single 'smart' insulin injection regulates glucose levels in mice and minipigs up to one week

Single 'smart' insulin injection regulates glucose levels in mice and minipigs up to one week

by Bob Yirka , Medical XpressDually glucose-responsive complex for insulin delivery. Schematic of complex formation and insulin release with dual glucose-responsive mechanisms. The negatively charged
Diabetes & Endocrinology March 14,2024
Single 'smart' insulin injection regulates glucose levels in mice and minipigs up to one week

Single 'smart' insulin injection regulates glucose levels in mice and minipigs up to one week

by Bob Yirka , Medical XpressDually glucose-responsive complex for insulin delivery. Schematic of complex formation and insulin release with dual glucose-responsive mechanisms. The negatively charged
Diabetes & Endocrinology March 14,2024
3-D printed ankle joints help patients walk again

3-D printed ankle joints help patients walk again

by Georgia Gowing,Macquarie UniversityCredit: Pixabay/CC0 Public DomainIn a world where hip and knee replacements have become common, orthopedic surgeons remain surprisingly divided over ankle r
Arthritis and Rheumatism March 14,2024
3-D printed ankle joints help patients walk again

3-D printed ankle joints help patients walk again

by Georgia Gowing,Macquarie UniversityCredit: Pixabay/CC0 Public DomainIn a world where hip and knee replacements have become common, orthopedic surgeons remain surprisingly divided over ankle r
Arthritis and Rheumatism March 14,2024
Diabetic retinopathy tied to lower vision-related quality of life

Diabetic retinopathy tied to lower vision-related quality of life

by Lori SolomonVision-related quality of life (VRQoL) declines with the presence and higher severity of diabetic retinopathy (DR), according to a review published online Feb. 1 inJAMA Ophthalmol
Diabetes & Endocrinology March 14,2024
Diabetic retinopathy tied to lower vision-related quality of life

Diabetic retinopathy tied to lower vision-related quality of life

by Lori SolomonVision-related quality of life (VRQoL) declines with the presence and higher severity of diabetic retinopathy (DR), according to a review published online Feb. 1 inJAMA Ophthalmol
Diabetes & Endocrinology March 14,2024
High weekly physical activity levels linked to lower kidney disease risk in diabetes and overweight/obesity

High weekly physical activity levels linked to lower kidney disease risk in diabetes and overweight/obesity

by British Medical JournalCredit: CC0 Public DomainClocking up high weekly levels of moderate to vigorous intensity physical activity is linked to a lower risk of developing chronic kidney diseas
Diabetes & Endocrinology March 14,2024
High weekly physical activity levels linked to lower kidney disease risk in diabetes and overweight/obesity

High weekly physical activity levels linked to lower kidney disease risk in diabetes and overweight/obesity

by British Medical JournalCredit: CC0 Public DomainClocking up high weekly levels of moderate to vigorous intensity physical activity is linked to a lower risk of developing chronic kidney diseas
Diabetes & Endocrinology March 14,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com